<DOC>
	<DOCNO>NCT00785759</DOCNO>
	<brief_summary>Study Assess Brain Uptake Safety AH110690 ( 18F ) Injection Subjects Probable Alzheimer 's Disease , Amnestic Mild Cognitive Impairment Healthy Volunteers .</brief_summary>
	<brief_title>Brain Uptake Safety With Probable Alzheimer 's Disease , Amnestic Mild Cognitive Impairment Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<criteria>The subject meet National Institute Neurological Communicative Disorders Stroke ; Alzheimer 's Disease Related Disorders Association ( NINCDSADRDA ) criteria clinically probable AD Diagnostic Statistical Manual Mental Disorders , 4th Edition ( DSMIV ) criteria dementia Alzheimer 's type . The subject meet Petersen criterion amnestic MCI . The subject evidence cognitive impairment medical history . The subject may able complete study judge investigator . The subject receive ionising radiation exposure clinical trial last 12 month participate clinical study within 30 day study entry . The subject know allergy [ 18F ] AH110690 [ 11C ] PIB constituent . The subject pregnant breastfeeding . The subject history alcohol and/or drug abuse within last 2 year base upon review medical record . The subject contraindication MRI ( include , limited , claustrophobia , pacemaker , presence metallic fragment near eye spinal cord , cochlear implant ) . The subject history head injury loss consciousness .</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Alzheimer 's Disease</keyword>
</DOC>